Savient Pharmaceuticals, Inc: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report

iCD Research
February 6, 2012
35 Pages - SKU: ICDR6792816
License type:
Table of Contents Search inside this report Related Reports
Synopsis

ICD Research's Savient Pharmaceuticals, Inc: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report contains in depth information and data about the company and its operations. The profile contains a company overview, business description, competitive benchmarking, SWOT analysis, key facts, information on products and services, details of locations and subsidiaries, plus information on key news events affecting the company.

Summary

ICD Research's Savient Pharmaceuticals, Inc: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report is a crucial resource for industry executives and anyone looking to access key information about Savient Pharmaceuticals, Inc..

ICD Research's Savient Pharmaceuticals, Inc: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. ICD Research strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report.

Scope
  • Examines and identifies key information and issues about Savient Pharmaceuticals, Inc. for business intelligence requirements.
  • Studies and presents the company's strengths, weaknesses, opportunities (growth potential) and threats (competition). Strategic and operational business information is objectively reported.
  • Provides data on company financial performance and competitive benchmarking.
  • The profile also contains information on business operations, company history, major products and services, prospects, key employees, locations and subsidiaries.
Reasons To Buy
  • Quickly enhance your understanding of Savient Pharmaceuticals, Inc. .
  • Gain insight into the marketplace and a better understanding of internal and external factors which could impact the industry.
  • Increase business/sales activities by understanding your competitors’ businesses better.
  • Recognize potential partnerships and suppliers.
Key Highlights

Savient Pharmaceuticals, Inc. (Savient) is a specialty pharmaceuticals company, which develops, manufactures and markets pharmaceutical products. Formerly known as Bio-Technology General, Savient sells and distributes Oxandrin and oxandrolone which promotes weight gain. The company's major recent product is KRYSTEXXA developed for the treatment of chronic gout, which was approved by the U.S. Food and Drug Administration (FDA) in September 2010. The company principally operates in the US after it sold its subsidiaries in UK and Israel. The company sold its Rosemont Pharmaceuticals, Ltd in UK, to Ingleby Limited and BTG, a biologics manufacturing business in Israel to Ferring. Savient is headquartered in New Jersey, the US.


 

Share this report


Other tasks

 
 

Research Assistance

Ask a question
 

Related Markets


Pharmaceuticals Company Reports

 
 

Free Alert Me service

Receive bi-weekly email alerts on new market research

Sign Up Today!